Dogwood Therapeutics, Inc. financial data

Symbol
DWTX on Nasdaq
Location
Alpharetta, GA
Fiscal year end
31 December
Latest financial report
18 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 533% % 16%
Debt-to-equity 61% %
Return On Equity -143% % -110%
Return On Assets -36% % 24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33,401,553 shares 1648%
Common Stock, Shares, Outstanding 29,743,516 shares 2133%
Entity Public Float $8,092,720 USD 41%
Common Stock, Value, Issued $2,974 USD 2136%
Weighted Average Number of Shares Outstanding, Basic 4,977,446 shares 384%
Weighted Average Number of Shares Outstanding, Diluted 4,977,446 shares 384%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $21,866,071 USD 519%
General and Administrative Expense $6,102,374 USD -30%
Operating Income (Loss) $27,968,445 USD -129%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $34,036,274 USD -176%
Net Income (Loss) Attributable to Parent $34,257,370 USD -177%
Earnings Per Share, Basic -7.13 USD/shares 43%
Earnings Per Share, Diluted -7.13 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,524,744 USD -56%
Assets, Current $8,431,206 USD -49%
Property, Plant and Equipment, Net $12,754 USD -24%
Operating Lease, Right-of-Use Asset $163,140 USD -21%
Intangible Assets, Net (Excluding Goodwill) $68,985,026 USD 5%
Goodwill $12,401,118 USD 5%
Assets $90,171,237 USD -4.4%
Accounts Payable, Current $760,945 USD -38%
Employee-related Liabilities, Current $745,080 USD 1.1%
Accrued Liabilities, Current $2,241,417 USD 18%
Liabilities, Current $3,059,203 USD -3.7%
Deferred Income Tax Liabilities, Net $12,109,404 USD 7%
Operating Lease, Liability, Noncurrent $105,763 USD -32%
Other Liabilities, Noncurrent $15,381,077 USD
Liabilities $15,274,370 USD -49%
Accumulated Other Comprehensive Income (Loss), Net of Tax $587,039 USD 85%
Retained Earnings (Accumulated Deficit) $108,076,316 USD -46%
Stockholders' Equity Attributable to Parent $74,896,867 USD
Liabilities and Equity $90,171,237 USD -4.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,682,554 USD -400%
Net Cash Provided by (Used in) Financing Activities $7,372,378 USD
Common Stock, Shares Authorized 43,000,000 shares 0%
Common Stock, Shares, Issued 29,751,234 shares 2120%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,524,744 USD -56%
Deferred Tax Assets, Valuation Allowance $36,952,112 USD 18%
Deferred Tax Assets, Gross $37,437,665 USD -2.2%
Operating Lease, Liability $162,604 USD -21%
Depreciation $17,022 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $30,981,422 USD -91%
Lessee, Operating Lease, Liability, to be Paid $179,229 USD -23%
Property, Plant and Equipment, Gross $12,754 USD -31%
Operating Lease, Liability, Current $56,841 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $68,252 USD 6.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $67,062 USD 5.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.0782 pure 0%
Deferred Income Tax Expense (Benefit) $188,752 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $16,625 USD -44%
Lessee, Operating Lease, Liability, to be Paid, Year Three $43,915 USD -32%
Deferred Tax Assets, Operating Loss Carryforwards $27,632,096 USD 5.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,997,786 shares -0.11%
Lessee, Operating Lease, Liability, to be Paid, Year Four $41,829 USD
Operating Lease, Payments $121,351 USD -0.1%
Additional Paid in Capital $183,856,376 USD 171%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $485,553 USD -93%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%